| Gender | Total | ||||||
Male | Female | |||||||
Modes of Action | Antimicrobial Category | Antibiotics | Sensitive | Resistant | Sensitive | Resistant | Sensitive | Resistant |
Cell wall synthesis inhibitors | Aminopenicillin
Extended-spectrum Cephalosporins
Carbapenems
| Amoxiclav (30 mcg)
Ceftriaxone (30 mcg) Cefepime (30 mcg) Ceftazidime (30 mcg)
Imipenem (10 mcg) Meropenem (10 mcg)
| -
- 3 3
- - | 72
72 69 69
72 72 | -
1 1 2
- - | 31
30 30 29
31 31 | -
1 4 5
- - | 103
102 99 98
103 103 |
Cell membrane | Polypeptide antibiotics | Polymyxin (300 mcg) | 63 | 9 | 31 | - | 94 | 9 |
Protein synthesis inhibitors | Aminoglycosides
Tetracyclines
| Amikacin (30 mcg) Gentamicin (10 mcg) Netilmicin(30 mcg)
Tetracycline (30 mcg) Tigecycline (15 mcg) | 8 7 6
12 55 | 64 65 66
60 17 | 3 4 3
7 28 | 28 27 28
24 3 | 11 11 9
19 83 | 92 92 94
84 20 |
Nucleic acid synthesis inhibitors | Fluoroquinolones | Ciprofloxacin (5 mcg) Levofloxacin (5 mcg) | 2 4 | 70 68 | 2 2 | 29 29 | 4 6 | 99 97 |
Folate pathway inhibitors | Trimethoprim and Sulfamethoxazole | Cotrimoxazole (25 mcg) | 9 | 63 | 5 | 26 | 14 | 89 |